Prevention of Cardiovascular Diseases

Dear Colleagues,

We are in the midst of a revolution in the prevention and management of cardiovascular disease, with the emergence of new drugs and new targets associated with improved cardiovascular outcomes. At the same time, advances in risk assessment, including novel biomarkers, genetics, and noninvasive subclinical atherosclerosis imaging represent major advances that will be implemented more widely in the coming years. Issues related to primary and secondary prevention are becoming increasing complex, and more and more patients are seeking specialized advice on cardiovascular risk assessment and management. This issue of Reviews in Cardiovascular Medicine tackles these bold issues and provides a glimpse into the next frontiers in prevention of cardiovascular disease.

Prof. Dr.  Michael D. Shapiro

Guest Editor

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.